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The signalling molecule bis-(39–59)-cyclic-dimeric guanosine monophosphate (c-di-GMP) is a
central regulator of diverse cellular functions, including motility, biofilm formation, cell cycle
progression and virulence, in bacteria. Multiple diguanylate cyclase and phosphodiesterase-
domain-containing proteins (GGDEF and EAL/HD-GYP, respectively) modulate the levels of the
second messenger c-di-GMP to transmit signals and obtain such specific cellular responses. In
the genus Bordetella this c-di-GMP network is poorly studied. In this work, we evaluated the
expression of two phenotypes in Bordetella bronchiseptica regulated by c-di-GMP, biofilm
formation and motility, under the influence of ectopic expression of Pseudomonas aeruginosa
proteins with EAL or GGDEF domains that regulates the c-di-GMP level. In agreement with
previous reports for other bacteria, we observed that B. bronchiseptica is able to form biofilm and
reduce its motility only when GGDEF domain protein is expressed. Moreover we identify a
GGDEF domain protein (BB3576) with diguanylate cyclase activity that participates in motility
and biofilm regulation in B. bronchiseptica. These results demonstrate for the first time, to our
knowledge, the presence of c-di-GMP regulatory signalling in B. bronchiseptica.
INTRODUCTION
Bis-(39–59)-cyclic-dimeric guanosine monophosphate (c-
di-GMP) is a bacterial second messenger known to regulate
a variety of cellular processes. c-di-GMP has been found to
stimulate biofilm formation, inhibit motility and control
the virulence of bacterial pathogens (Jenal & Malone, 2006;
Kolter & Greenberg, 2006; Römling & Amikam, 2006;
Hengge, 2009).
c-di-GMP is produced from two molecules of GTP by
diguanylate cyclases (DGCs) and hydrolysed by a c-di-
GMP-specific phosphodiesterases (PDE). DGC activity is
conferred by the GGDEF functional domain, whereas PDE
activity is performed by unrelated EAL or HD-GYP
domains (Römling & Amikam, 2006). Notably, individual
bacterial genomes frequently encode numerous GGDEF
and EAL/HD-GYP proteins (Galperin, 2004, 2005),
implying that the c-di-GMP network is a highly complex
and tightly regulated intracellular signalling system. The
observation that most GGDEF and EAL domains are linked
directly or through a two-component phosphorylation
cascade (Galperin, 2006) to input signal domains (includ-
ing PAS, blue-light-sensing, Cache, CHASE and MASE
domains) implies that numerous environmental and
internal signals can be integrated into the c-di-GMP
network.
Bordetella bronchiseptica is a Gram-negative bacterium that
causes respiratory tract infections in mammals, producing
atrophic rhinitis in pigs, kennel cough in dogs and snuffles
in rabbits (Goodnow, 1980). B. bronchiseptica has a variety
of virulence factors and strategies that allows the host
infection. Each factor such as pertactin (PRN), filamentous
haemagglutinin (FHA), adenylate cyclase (AC), the type
three secretory system (TTSS) and LPS are likely to
perform specific functions required for successful coloniza-
tion (Harvill et al., 1999, 2000; Sisti et al., 2002; Skinner
et al., 2004; Inatsuka et al., 2010). The BvgAS two-
component system plays a central role in the regulation of
some of these factors such as PRN, FHA, AC and TTSS
(Mattoo & Cherry, 2005). This system comprises a
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Abbreviations: AC, adenylate cyclase; c-di-GMP, bis-(39–59)-cyclic-
dimeric guanosine monophosphate; Ct, threshold cycle; CV, crystal
violet; DGC, diguanylate cyclase; FHA, filamentous haemagglutinin; NA,
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electron microscopy; TTSS, type three secretory system.
Two supplementary tables, listing plasmids and strains used and primers
used in PCRs, are available with the online version of this paper.
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histidine kinase sensor protein, BvgS, and a DNA-binding
response regulator protein, BvgA. In response to envir-
onmental signals, BvgAS undergoes a series of phosphor-
elay signal transduction events that ultimately lead to
differential transcription of target genes (Mattoo & Cherry,
2005). Growth at 37 uC in low concentrations of nicotinic
acid (NA) and magnesium sulfate leads to the Bvgplus or
virulent phase, in which BvgAS activates expression of
most known virulence factors. When the Bordetellae are
grown at low temperatures (below 26 uC) or in the
presence of millimolar concentrations of NA or magnes-
ium sulfate, BvgAS is inactivated, resulting in the Bvgminus
or avirulent phase, in which transcription of most virulence
factor genes is repressed and the expression of other factors
is induced, resulting in the maximal expression of motility
loci and genes required for the production of urease
(Akerley & Miller, 1993; Akerley et al., 1992; McMillan
et al., 1996). Intermediate phase, called Bvgi (Bvg inter-
mediate), occurs transiently during shifts between the Bvgplus
and Bvgminus states and can be induced by the addition of
magnesium sulfate or NA at concentrations lower than those
needed to fully induce the Bvgminus phase (Cotter and Miller,
1997). The Bvgi phase is characterized by the expression of a
subset of the Bvgplus-phase genes (such as fhaB and prn) and
Bvgi-specific genes (such as bipA and bcfA) (Cotter and
Miller, 1997; Stockbauer et al., 2001).
The ability of this genus to form biofilms has been reported
in previous work, with other authors reporting the ability
of B. bronchiseptica to form biofilm-like structures on
abiotic surfaces regulated by the two-component system
BvgAS (Irie et al., 2004; Mishra et al., 2005). Static growth
with intermediate NA concentrations represented the best
conditions for biofilm formation (Mishra et al., 2005). Like
in other biofilms, extracellular DNA and exopolysaccharide
are important for biofilm formation in B. bronchiseptica
(Conover et al., 2011). Sloan and colleagues even observed
these structures in vivo in the nasal epithelium of mice
infected with B. bronchiseptica. Those structures present a
polysaccharide essential for in vivo biofilm development
(Sloan et al., 2007). However, the exact mechanism of this
process and the bacterial factors involved has not been yet
determined.
Although the cyclic-di-GMP signalling system has been
characterized in several types of bacteria regulating biofilm
formation and motility, the understanding of this import-
ant signalling mechanism is limited in Bordetella spp. So far
there are no reports relating the c-di-GMP network to a
specific phenotype in B. bronchiseptica. In the published
genome of B. bronchiseptica RB50 strain there are four
hypothetical proteins with EAL domains, ten with GGDEF
domains and five with both domains (Amikam & Galperin,
2006). A recent study has identified a GGDEF diguanylate
cyclase type protein with ability to synthesize c-di-GMP
from the genome sequence of B. pertussis Tohama I.
Deletion of the gene encoding this enzyme diminished the
capacity of B. pertussis to adhere to abiotic surfaces (Wan
et al., 2009).
In the present work, we demonstrated that c-di-GMP
signalling is present in B. bronchiseptica by introducing
genes coding for proteins with proven PDE or DGC
activity. Phenotypes previously linked with the presence of
c-di-GMP in other bacteria were analysed, particularly
biofilm formation and motility in soft agar. We also
describe BB3576, a probable DGC, involved in swimming
motility regulation and biofilm formation. The results
reported here strongly suggest that c-di-GMP regulates
these phenotypes in B. bronchiseptica.
METHODS
Bacterial strains and growth conditions. Strains and plasmids
used in this study are listed in Table S1 available with the online
version of this paper. B. bronchiseptica strains were grown on Bordet
Gengou agar (Britania) supplemented with 10 % (v/v) defibrinated
fresh sheep blood (BGA medium) at 37 uC for 48 h and replated in
the same medium for 24 h. Escherichia coli (DH5-a and S17-1) and
Pseudomonas fluorescens Pf0-1 strains were routinely cultured with
liquid LB medium in a test tube or on solidified LB with 1.5 % (w/v)
agar. Proteins with DGC (PA1120) and PDE (PA3947) domains were
overexpressed in B. bronchiseptica 9.73 by using vectors with the
inducible tac promoter to assess the consequences of alterations in c-
di-GMP levels. Plasmids were introduced into B. bronchiseptica or in
Pseudomonas fluorescens Pf0-1 by electroporation and transformants
were selected in the presence of gentamicin (50 mg ml21).
B. bronchiseptica protein BB3576 was overexpressed in B. bronchi-
septica by using broad-host-range plasmid pBBR1MCS-5 with a
constitutive promoter nptII (Dombrecht et al., 2001) cloned by us in
SacI and XbaI sites of the pBBR1MCS-5 multiple cloning site. Proof
reading Pfx taq polymerase was employed to amplify the BB3576 gene
from B. bronchiseptica 9.73 with primers BB3576FXhoI (59ATGC-
CTCGAGGACGGGGTCGGATAAGGATA39) and BB3576RKpnI (59CTG-
AGGTACCTTCGGTCAGGAACGCAGGTC39). PCR conditions were
94 uC for 4 min (1 cycle), followed by 35 cycles of 94 uC for 20 s, 58 uC
for 20 s, and 68 uC for 2 min and a final extension of 68 uC for 5 min.
Underlined portions indicated restriction enzyme sites. Underlined
portions indicated restriction enzyme sites. The PCR product was
digested with XhoI and KpnI and cloned into pBB1RMCS-5-nptII
(renamed pEmpty) that had been digested with the same enzymes, to
generate pBB3576. Constructs were confirmed by sequencing. Plasmids
were transferred into B. bronchiseptica 9.73 or into Pseudomonas
fluorescens Pf0-1 by electroporation and transformants were selected in
the presence of gentamycin (50 mg ml21).
Biofilm assays. B. bronchiseptica biofilm formation assays using
static cultures were performed as described previously (Irie et al.,
2004) from overnight cultures into Stainer–Scholte (SS) liquid
medium (Stainer & Scholte, 1970). The overnight culture was diluted
to OD650 0.1, pipetted into each well of a sterile 96-well U-bottom
microtitre plate (both polycarbonate and PVC surfaces) and
incubated statically at 37 uC with NA or magnesium sulfate at
different concentrations. 1 mM IPTG and gentamicin (50 mg ml21)
were added, when appropriate.
For P. fluorescens biofilms an aliquot (1.5 ml) of an overnight culture
grown in LB was transferred into 100 ml K10T-1 medium in a 96-well
plate (353911; BD Falcon) and grown statically for 6 h at 30 uC. K10T-
1 medium, used in prior studies as a biofilm-promoting, phosphate-
rich medium, contains 50 mM Tris/HCl (pH 7.4), 0.2 % (w/v) Bacto
tryptone, 0.15 % (v/v) glycerol, 0.6 mM MgSO4 and 1 mM K2HPO4
and was prepared as described previously (Newell et al., 2011).
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In all assays planktonic bacteria were removed and remnant cells were
stained with 0.1 % crystal violet solution (CV). The stain was
dissolved by adding 120 ml 33 % acetic acid solution. A 100 ml sample
was transferred to a microplate and then quantified by measuring
OD595. Each data point results from an average for six wells and each
experiment was repeated at least three times with similar results.
Figures are representative of one of those replicates.
Measurements of c-di-GMP levels. c-di-GMP levels were analysed
via LC-MS. Strains of interest were grown in BGA media for 24 h.
Four replicates of each strain was harvested and resuspended in 250 ml
extraction buffer [methanol : acetonitrile : water (40 : 40 : 20) plus
0.1 M formic acid at 220 uC] and incubated at 220 uC for 30 min.
The cell debris was pelleted for 5 min at 4 uC, and the supernatant
containing the nucleotide extract was saved. Samples were immedi-
ately adjusted to a pH of approximately 7.5 with 15 % (NH4)2HCO3
and stored on dry ice prior to analysis. The resultant extract was
analysed via LC-MS using the LC-20AD HPLC system (Shimadzu)
coupled to a Finnigan TSQ Quantum Discovery MAX triple-
quadrupole mass spectrometer (Thermo Electron) as previously
described (Newell et al., 2011).
Motility assays. SS soft-agar motility plate [0.35 % (p/v) agar]
supplemented with MgSO4 40 mM and 1 mM IPTG was used to
determine the motility of bacterial strains as previously described
(Fernández et al., 2005). The diameter of the migration zone was
measured after 18 h of incubation at 37 uC.
Scanning electron microscopy (SEM). Bordetella strains were
cultured statically on glass coverslips partially submerged vertically in
1.5 ml plastic tubes (Mishra et al., 2005). The glass coverslips were
placed such that an air–liquid interface was established. After 48 h the
coverslip was removed and washed with sterile PBS (KH2PO4 3 mM,
Na2HPO4 10 mM, NaCl 120 mM), and the bacteria were fixed with
2.5 % glutaraldehyde. Samples were dehydrated in a graded ethanol
series (20, 50, 70, 90 and 100 % for 60 min each), dried by critical point
using liquid carbon dioxide (EMITECH, K850) and sputter coated with
gold. The surface topographies of the biofilm were visualized with a
scanning electron microscope (Philips SEM 505), and the images were
processed [Image Soft Imaging System ADDA II (SIS)].
RNA extraction and qPCR quantification. RNA preparation from
bacteria was performed using the Illustra RNAspin kit (GE). Samples
were placed on ice, and quantification of RNA was performed using a
ND-1,000 NanoDrop spectrophotometer at 260 nm. Measurements of
A260/A280 were used to determine the purity of the RNA. DNase
(Promega) treatment was performed according to manufacturer’s
instructions in order to eliminate contaminating DNA. The synthesis
of cDNA was performed with a Reverse Transcription System kit
(Promega) according to the manufacturer’s protocol using random
primers. For each sample 1 mg RNA was used. The reaction was
incubated at room temperature for 10 min, and reverse transcription
was performed in a thermal cycler at 42 uC for 15 min and 95 uC for
5 min. qPCR conditions were 95 uC for 10 min (1 cycle), followed by 40
cycles of 60 uC for 30s, 95 uC for 15 s and a final increasing temperature
cycle between 55 and 95 uC for 10 s when melt curve data was obtained.
Samples were placed on ice for 5 min to stop the reaction. Samples that
had not undergone the reverse transcription process were used as
controls for genomic DNA absence in real-time PCR experiments. Only
samples with threshold cycle (Ct) values above mock values were used in
further experiments. Real-time PCR were performed using the SYBR
green master mix 26 (Bio-Rad). Primers employed are summarized in
Table S2. All samples, including a negative control using mock samples
instead of DNA, were run in triplicates. The data were analysed using Ct
calculations using recA expression levels as a normalizer. Results were
expressed as fold increase over values from bacteria growth in SS media
without additional NA.
Statistical analyses. All the results were compared by ANOVA
followed by the Tukey test. A value of P,0.01 was considered
significant. To identify significant differences in RNA expression, Ct
values were analysed using the REST program.
RESULTS
B. bronchiseptica biofilm formation is enhanced
by diguanylate cyclase activity
Because some authors have described that not all proteins
with GGDEF domains have DGC activity, we first decided
to use a protein with known in vitro and in vivo DGC
activity in our studies (Kulesekara et al., 2006). Protein
PA1120 with DGC activity was overexpressed in B.
bronchiseptica 9.73 (Bb-DGC) by using a vector with the
inducible tac promoter. Clone Bb-DGC grown in IPTG-
containing media overexpressed PA1120 and this strain
was able to grow in a batch culture at the same rate as the
parental strain (data not shown). The ability to form
biofilm was evaluated by the crystal violet method in 96-
well polycarbonate U-bottom and polyvinylchloride (PVC)
microtitre plates as described in Methods. Biofilm
formation is regulated by the BvgAS two-component
system (Irie et al., 2004; Mishra et al., 2005). Hence, we
determined the amount of biofilm biomass formed by
strains under Bvg-modulated-phase conditions in the
presence of NA (0–8.0 mM). This chemical compound
serves as an environmental modulator of BvgAS activity
(Akerley et al., 1992), at 0 mM NA the BvgAS system
should be fully activated or in Bvgplus phase and at 8 mM
NA the BvgAS system should be fully inactivated or in
Bvgminus phase. In our hands, B. bronchiseptica 9.73
(BbWT) strain showed biofilm formation on both poly-
carbonate and PVC surfaces and the biofilm pellicle was
enhanced in intermediate modulation conditions in
agreement with results for B. bronchiseptica RB50 strain
(Irie et al., 2004). In Fig. 1(a) results obtained on
polycarbonate surface are shown and are similar to PVC
results (not shown). As expected for a high c-di-GMP
intracellular concentration, overexpression of PA1120 in
Bb-DGC significantly enhanced pellicle formation at NA
concentrations from 0 to 4.0 mM (Fig. 1a) compared with
the parental strain. This difference was observed only when
IPTG-supplemented SS was used. Surprisingly, when
PA1120 was overexpressed biofilm formation was particu-
larly exacerbated in the Bvgminus phase (4.0 mM NA; Fig. 1a).
We observed no biofilm formation in 8.0 mM NA media,
but planktonic growth in that condition was significantly
slower compared with that for media without additional NA
(data not shown). On the other hand, overexpression of
PA3947 with PDE activity produced a biologically significant
decrease in the biofilm formation as compared with the
parental strain only in 1.0 mM NA (Fig. 1a).
The BvgAS system is downregulated by NA and by mag-
nesium sulfate. For that reason, we performed biofilm quan-
tification with different magnesium sulfate concentrations
c-di-GMP regulates biofilm and motility in Bordetella
http://mic.sgmjournals.org 871
corresponding to Bvgplus, Bvgi and Bvgminus phases, as
reported previously (Williams & Cotter, 2007). We
observed that biofilm formation was also enhanced in
Bb-DGC at Bvgi (16 mM) and Bvgminus (32 mM)
magnesium sulfate-induced phases compared with the
parental strain (Fig. 1b).
In order to confirm that NA concentrations corresponded to
established phases in BbWT like in the sequenced B.
bronchiseptica strain RB50, mRNA extraction and quantifica-
tion was performed. Bacteria cultures grown in SS with NA at
concentrations between 0 and 4.0 mM were subject to mRNA
purification. Levels of cyaA (AC, Bvgplus phase factor), bipA
(Bvgi phase factor) and flaA (flagellin, Bvgminus phase factor)
mRNA were normalized to recA and compared. Results
obtained confirmed that with NA in the concentrations
assayed all the virulence phases were detected, 0.5 mM NA
and 1 mM NA correspond to Bvgi phase and 4 mM NA
corresponds to Bvgminus phase. (Fig. 2).
Overexpression of a diguanylate cyclase in B.
bronchiseptica induced increased intracellular
c-di-GMP levels
In order to confirm that PA1120 overexpression in Bb-
DGC correlated with increased DGC activity in vivo, intra-
cellular c-di-GMP levels were determined. Cultures with or
without IPTG induction were subjected to c-di-GMP
extraction and analysis. As shown in Fig. 3, Bb-DGC in the
presence of IPTG presented significantly higher c-di-GMP
levels than the strain grown under non-inducing condi-
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Fig. 1. Effect of DGC or PDE overexpression in B. bronchiseptica biofilm formation. Biofilm development by BbWT, Bb-DGC
and Bb-PDE cultured in SS medium either alone or supplemented with NA (a) or magnesium sulfate (b). Biofilm formation was
assessed by polycarbonate microtitre plate assays as described in Methods. * P,0.01 vs BbWT grown in SS; ** P,0.01 vs




































Fig. 2. mRNA expression of B. bronchiseptica 9.73 Bvg-regulated
factors at different nicotinic acid concentrations. mRNA transcripts
levels of cyaA (Bvgplus gene), bipA (Bvgi gene) and flaA (Bvgminus
gene) were quantified by qPCR compared with the constitutive
recA gene. Values were normalized to levels observed in SS media
































Fig. 3. In vivo assessments of DGC activity in B. bronchiseptica.
Quantitative measurements of cellular c-di-GMP from the Bb-
DGC strain compared with BbWT. Formic acid-extracted c-di-
GMP was measured by LC-MS and normalized to mg dry weight
of bacteria after extraction. The difference observed was significant
(P,0.001).
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observed in Bb-DGC were a consequence of increased c-di-
GMP level.
Scanning electron microscopy of B.
bronchiseptica cells adhered to glass coverslips
To further investigate the consequences of DGC activity in
biofilm development, biofilms formed at the air–liquid
interface in biphasic cultures on glass coverslips were
observed by SEM. As expected for Bvgi conditions, at 48 h
all strains grown in 1.0 mM NA presented thick multi-
layered stack of cells alternated with stacked cells
aggregated in clusters similar to those observed by other
authors (Fig. 4) (Mishra et al., 2005). Wild-type cells
grown in Bvgplus phase (0 mM NA) formed a thin layer
with small aggregates, whereas cells grown in Bvgminus
phase (4.0 mM NA) appear as diffuse, interspersed
bacteria (Fig. 4). Interestingly, SEM analysis of Bb-DGC
biofilms revealed stacked bacteria more frequently and
with bigger dimensions, resulting in an architecture that
appeared to encase the bacterial microcolonies. These
structures were observed in all virulence phases tested. In
the case of Bb-PDE, cells grown at Bvgplus (0 mM NA) or
Bvgminus (4.0 mM NA) phase were spread around the
disks with large regions remaining uncolonized.
Altogether these results further corroborate those from
CV quantification for Bb-DGC, with the exception that no
differences were observed at 1.0 mM NA between Bb-PDE
and BbWT in this analysis.
BvgA is not necessary for diguanylate-cyclase-
dependent biofilm formation
Bacterial proteins that mediate c-di-GMP turnover and signal
transduction are often composed of multiple domains,
allowing for a variety of regulatory inputs (Galperin et al.,
2001). In particular, interplay between c-di-GMP network and
two-component systems has been observed in many bacteria
(Lai et al., 2009; Mikkelsen et al., 2009). B. bronchiseptica
biofilm formation was dependent on Bvg phase conditions
and c-di-GMP signalling as described above, indicating a
probable connection between the two regulatory systems.
As described above, biofilm formation was dependent on
Bvg phase condition even if high c-di-GMP intracellular
levels were induced. A hypothesis to explain this obser-
vation is that the BvgAS system controls c-di-GMP levels.
However, quantification of intracellular c-di-GMP levels
under different Bvg-modulated conditions shows no
significant differences between c-di-GMP concentrations
(Fig. 5a), thus we must reject this hypothesis.
Although c-di-GMP concentration was apparently inde-
pendent of direct BvgAS regulation, we assessed the effect













Fig. 4. SEM images of B. bronchiseptica biofilms. BbWT (upper row of panels), Bb-DGC (middle row of panels) and Bb-PDE
(bottom row of panels) were grown statically on vertically submerged coverslips in SS medium alone (left column of panels), SS
supplemented with 1.0 mM NA (middle column of panels) or SS supplemented with 4.0 mM NA (right column of panels). After
48 h of growth, the biofilms formed at the air–liquid interface were visualized by SEM.
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overexpressed PA1120 with DGC activity in B. bronchi-
septica DBvgA (BbDBvgA), a mutant locked in the
BvgAminus phase and previously constructed by our group
(Fernández et al., 2005). All strains were assayed for biofilm
formation in 96-well polycarbonate U bottom plates. As
expected, BbDBvgA showed poor biofilm formation in all
Bvg modulatory conditions, similar to the BvgAminus phase
(Fig. 5b). However, when PA1120 in BbDBvgA-DGC was
overexpressed, significantly higher biofilm formation was
detected at NA concentrations lower than 8.0 mM.
Biofilms produced by DGC-expressing bacteria in a DBvgA
background were analysed by SEM. As shown in Fig. 5(c),
BbDBvgA-DGC in 1.0 mM NA was the only strain and condition
that formed a uniform multilayered stack of cells, but the volume
of the structure was smaller than that for Bb-DGC, corroborating
the CV determinations (Fig. 4). As expected, BbDBvgA showed
no distinct region of biofilm formation and cells were spread
evenly across the coverslips (Fig. 5c).
c-di-GMP regulates swimming motility in B.
bronchiseptica
In several bacteria c-di-GMP suppresses swimming,
swarming and twitching motility (Jenal & Malone, 2006;
Römling & Amikam, 2006). Flagellar expression and
motility in B. bronchiseptica is regulated by the BvgAS
two-component system and is maximal in the BvgAminus
phase (Akerley et al., 1992). Therefore, we evaluated strain
motility in the presence of modulating concentrations of
magnesium sulfate. As expected, all strains showed motility
in soft agar in modulated conditions. However, when DGC
overexpression was induced by IPTG in WT reduced
motility was observed (Fig. 6). This phenotype was
observed also in a DBvgA background. Bb-PDE showed
no significant differences from the wild-type strain with
regard to motility.
BB3576: a hypothetical GGDEF protein regulating
swimming motility and biofilm formation in B.
bronchiseptica
The B. bronchiseptica genome contains 15 proteins with
GGDEF domains. As observed above, DGC overexpression
in B. bronchiseptica inhibits swimming motility in soft agar.
In E. coli, swimming is regulated by c-di-GMP through
diverse DGCs and PDEs. Deletion of genes encoding
GGDEF proteins YeaI, YedQ, YfiN, YeaJ and YneF in E. coli
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Fig. 5. BvgA is not necessary for diguanylate-cyclase-dependent biofilm formation. (a). Quantitative measurements of cellular c-di-GMP
from B. bronchiseptica grown planktonically in BGA supplemented with different NA concentrations. Formic-acid-extracted c-di-GMP was
measured by LC-MS and normalized to mg dry weight of bacteria after extraction. (b) Biofilm formation by BbWT, Bb-DGC, BbDBvgA and
BbDBvgA-DGC cultured in SS medium either alone or supplemented with NA was analysed by CV staining after 24 h in static conditions.
(c) SEM of 48 h air–liquid interface submerged coverslips in SS medium alone (left panels), SS supplemented with 1.0 mM NA (middle
panels) or SS supplemented with 4.0 mM NA (right panels). * P,0.01 vs BbDBvgA grown at the same NA concentration.
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Also, YeaJ, YedQ and YfiN overexpression negatively
regulate motility without impairing it completely
(Pesavento et al., 2008). These results suggested that some
proteins with DGC activity are involved in fine-tuning
regulation of flagellar activity. Among these proteins, YeaJ
also has a Cache domain similar to the domain found in
the BB3576 protein of B. bronchiseptica. Swimming
motility in B. bronchiseptica is regulated mainly by the
two-component system BvgAS and is fully expressed in
Bvgminus phase. Hence we hypothesized that if BB3576 is
involved in motility regulation it should be expressed in
the Bvgminus phase. Bacteria grown in the presence of NA
were subjected to RNA extraction and subsequent cDNA
synthesis. qPCR relative quantification of BB3576 mRNA
demonstrated that BB3576 is expressed in all phases
tested and 36 times higher in the Bvgminus than in the
Bvgplus phase, suggesting that BB3576 protein may be
present when flagellar apparatus is functionally active
(Fig. 7a).
As was observed for Bb-DGC, overexpression of BB3576
should inhibit swimming motility in Bvgminus phase. The
BB3576 gene was cloned into a broad-host-range plasmid
pBB1RMCS-5 under control of the nptII constitutive
promoter and transferred to Bb-DGC to obtain Bb-
BB3576. These bacteria showed reduced swimming mot-
ility in soft agar compared with wild-type B. bronchiseptica
transformed with the empty vector (Fig. 7b). This
behaviour was also observed when BbDBvgA transformed
with the empty vector was compared with BbDBvgA–
BB3576 (data not shown).
As described above, DGC overexpression correlates with
impaired motility and enhanced biofilm formation in B.
bronchiseptica. Bb-BB3576 showed impaired swimming in
soft agar, hence we decided to evaluate if biofilm formation
was different from that of the wild-type strain. As expected
for a strain with high c-di-GMP levels, biofilm formation
of Bb-BB3576 was enhanced in Bvgi phase (1.0 mM NA)
compared with B. bronchiseptica transformed with the
empty vector (Fig. 7c). Furthermore, biofilm formation for
BbDBvgA–BB3576 in Bvgi phase was enhanced compared
with BbDBvgA transformed with the empty vector
(Fig. 7c).
BB3576 complements a diguanylate cyclase
mutant phenotype
The BB3576 protein expressed in B. bronchiseptica resulted
in phenotypes consistent with this protein being an active
DGC. To confirm that BB3576 has DGC activity, we
transformed the P. fluorescens D4DGC (PsD4) strain with
the pBB3576 plasmid. Strain PsD4 has the genes coding for
four DGC proteins deleted from its genome and is not able
to produce biofilm under static growth conditions (Newell
et al., 2011). A previous study showed that complementa-
tion with one DGC protein was sufficient to restore biofilm
formation to this strain (Newell et al., 2011). Biofilm
formation for the P. fluorescens strains was evaluated in a
96-well plate grown statically for 6 h at 30 uC in K10T-1
medium (Fig. 8). When PsD4 was complemented with a
DGC-encoding-gene gcbB, biofilm formation was restored
as previously described (Newell et al., 2011). When a
plasmid carrying BB3576 was introduced, biofilm forma-
tion was also observed, suggesting a DGC activity for this
protein in concordance with the results described above
(Fig. 8).
DISCUSSION
The signalling molecule c-di-GMP has been reported to
regulate phenotypes like biofilm formation, motility and
virulence. It is generated from two GTP molecules by
GGDEF-domain-containing DGC enzymes, and degraded
by PDE enzymes containing either EAL or HD-GYP
protein domains. Despite the frequent occurrence of these
protein domains encoded in bacteria genomes, informa-
tion on mechanisms and physiological roles regarding their
function and regulation is sparse. Many of these proteins
have also other domains, suggesting that c-di-GMP activity
is regulated by these additional domain functions. So we
can imagine that cell c-di-GMP turnover is regulated
through the consensus of various external and internal
factors. The balance of these signals ultimately regulates
biofilm formation, motility and virulence.
In the present work we showed that c-di-GMP signalling is
involved in B. bronchiseptica biology. We overexpressed
proteins with demonstrated in vitro and in vivo activity in
order to establish if c-di-GMP regulation was present in
this microbe. We overexpressed PA1120 or PA3947 with
known DGC and PDE activities, respectively, in wild-type
B. bronchiseptica. As shown in Fig. 1, PA1120 with a
GGDEF functional domain overexpression leads to an
enhanced biofilm phenotype compared with the wild-type






















BbWT Bb-DGC Bb-PDE BbΔBvgA BbΔBvgA-DGC
Fig. 6. Motility phenotypes of B. bronchiseptica strains. The
diameters of migration zones of the wild-type, overexpression
strains and mutants were measured and expressed relative to wild-
type diameter after 18 h of incubation at 37 6C on SS motility
plates supplemented with 32 mM magnesium sulfate. One
hundred per cent motility in BbWT was 12 mm. The results are
based on three replicates.
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quantified by the CV method and confirmed by SEM.
These findings suggest that an increase in the levels of this
DGC and in intracellular c-di-GMP levels causes an
enhanced production of factors that promote bacterial
binding to abiotic surfaces and/or inter-bacterial adherence.
As mentioned above, biofilm formation is regulated by
BvgAS in B. bronchiseptica. Nicotinic acid or magnesium
sulfate can modulate BvgAS activity in vitro through the
three phases, virulent (Bvgplus), intermediate (Bvgi) and
avirulent (Bvgminus). Interestingly, although for all modu-
lator conditions Bb-DGC showed more biofilm formation
than the parental strain, the difference is bigger in Bvgminus
phase (4.0 mM NA). Irie et al. (2004) suggested that while
AC activity inhibits biofilm formation, FHA is necessary
for full biofilm development. Both proteins are present in
Bvgplus phase but only FHA is present in Bvgi phase and
both are absent in Bvgminus phase (Mattoo & Cherry,
2005). This is in agreement with results showing that Bvgi
phase is the condition where major biofilm formation is
observed in B. bronchiseptica. Nevertheless, it is noteworthy
that with overexpression of a non-physiological DGC, and
in the absence of FHA during growth in the Bvgminus phase,
a biofilm is still established by the Bb-DGC strain. The
group of factors involved in biofilm regulation and
presumably activated by c-di-GMP might be sufficient
for establishment of this phenotype regardless of virulence
factors like FHA.
In concordance with this finding, when PA1120 was
overexpressed in a DBvgA background, biofilm formation
was observed. However, the biofilm magnitude was
significantly weaker than in wild-type background and
SEM analysis showed only biofilm architecture in 1.0 mM
NA. These results are surprising, since neither BbDBvgA
nor BbDBvgA-DGC is expected to respond to different
concentrations of known BvgAS modulators, thus the
interplay between NA and the c-di-GMP network may be
present in B. bronchiseptica through mechanisms not yet
explored. We can speculate that BvgAS regulates the c-di-
GMP network regulating protein expression, particularly
those proteins directly involved in c-di-GMP signalling.
Interestingly, the BvgR regulatory protein, which represses
the expression of virulence genes in Bvgplus phase in
Bordetella, contains an EAL domain (Merkel et al., 1998).

















































































0 mM 2.0 mM1.0 mM0.5 mM 4.0 mM
Fig. 7. Motility and biofilm phenotypes of B. bronchiseptica overexpressing BB3576. (a) mRNA transcripts levels of BB3576
were quantified by qPCR compared with the constitutive recA gene. Values were normalized to levels observed in SS media
without additional NA. (b) The diameters of migration zones of the wild-type strain with pBBR1MCS-5 plasmid alone (Bb-
pEmpty) or with the BB3576 gene (Bb-BB3576) were measured and expressed relative to Bb-pEmpty vector diameter after
18 h of incubation at 37 6C on SS motility plates supplemented with 32 mM magnesium sulfate. One hundred per cent motility
for Bb-pEmpty was 12 mm. The results are based on three replicates. * P,0.01 vs Bb-pEmpty. (c) Biofilm development by Bb-
BB3576 compared with Bb-pEmpty was assessed by microtitre plate assays as described in Methods. Biofilm level was
determined in a DBvgA background (BbDBvgA-BB3576 and BbDBvgA-pEmpty). * P,0.01 vs Bb-pEmpty grown at the same
modulator concentration, ** P,0.01 vs BbDBvgA-pEmpty grown at the same modulator concentration.
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system, strongly suggesting a relationship between the
BvgAS system and c-di-GMP that requires further
investigation.
In other bacteria where c-di-GMP function has been
determined, low c-di-GMP levels are frequently associated
in planktonic phenotypes with flagellar expression. As
shown above, DGC overexpression in B. bronchiseptica
enhanced biofilm formation, probably as a consequence of
high c-di-GMP levels, which may also repress motility in
Bb-DGC when a flagellar system is present. It is known that
B. bronchiseptica shows motility in Bvgminus-modulated
conditions like high-sulfate concentrations. Motility assays
in soft agar plates showed that Bb-DGC exhibited
significantly diminished motility. This result is in con-
cordance with behaviour of other bacteria and with a c-di-
GMP network that regulates the transition between sessile
and motile lifestyles of bacteria. Moreover, we described for
the first time, to our knowledge, in B. bronchiseptica a
protein with a GGDEF domain that probably had
diguanylate cyclase activity in vivo. Real-time PCR results
clearly demonstrated that BB3576 expression was higher in
Bvgminus phase compared with Bvgplus conditions.
However, NA regulation appears to be dominant over
BB3576 activity for biofilm formation, even in a DBvgA
background, since differences in biofilm quantification of
strains overexpressing BB3576 were only significant at NA
concentrations inducing the Bvgi phase. One possible
explanation is that conformational changes in the
expressed BB3576 protein may be required for optimal
DGC function. BB3576 has two predicted domains, a DGC
domain and an extracellular sensory Cache domain (Ca+2
channels, chemotaxis receptors). In general, Cache
domains sense stimuli present in the periplasm and
transmit signals to an output domain such as GGDEF,
resulting in a specific adaptive response (Anantharaman &
Aravind 2000; Galperin 2006). We speculate that BB3576
regulates biofilm and motility when a ligand binds to the
Cache domain. The nature of this ligand remains unknown
at the moment. Diguanylate cyclase activity was demon-
strated in vivo for BB3576 as shown in Fig. 8.
Overexpression of BB3576 in a P. fluorescens strain with a
low-DGC-activity background restored biofilm formation.
The partial complementation achieved by BB3576 may be
explained by the absence from the growth media of the
unknown ligand.
Recently, Amarasinghe and co-workers described YeaJ in
Salmonella enterica serovar Typhimurium as an active DGC
membrane protein involved in motility regulation and
exopolysaccharide production (Amarasinghe et al., 2013).
This protein, like BB3576, has a GGDEF domain with
demonstrated DGC activity and a putative Cache domain.
They proposed that the association of a protective
monoclonal IgA antibody with the O-antigen induces
outer membrane stress triggering a c-di-GMP signalling
pathway that effectively promotes a less motile and non-
invasive biofilm state, thereby rendering the bacterium
unable to invade intestinal epithelial cells. The particular
expression profile of BB3576 in Bvgplus, Bvgi and Bvgminus
phases is in concordance with putative motility regulation
of the bacteria during Bvgminus phase. Flagellar synthesis
and function is regulated in bacteria at different levels by c-
di-GMP (Wolfe & Visick, 2008). This newly described
protein BB3576 might fine tune flagellar motor function
using c-di-GMP as a second messenger in response to
chemosensory activity of the Cache domain, as reported for
E. coli (Pesavento et al., 2008).
Although further research is needed to elucidate c-di-GMP
regulation and signalling in B. bronchiseptica, we demon-
strated here for the first time, to our knowledge, its role
regarding the control of B. bronchiseptica biofilm formation
and motility. More over we would now argue that c-di-
GMP is involved in motility regulation in response to as yet
unknown ligands that may be sensed by BB3576.
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Fig. 8. BB3576 complements biofilm phenotype in a P.
fluorescens diguanylate cyclase mutant. Biofilm development by
the P. fluorescensD4DGC strain and P. fluorescensD4DGC
complemented with BB3576-expressing vector (PsD4-BB3576)
was determined by CV staining after 6 h growth in static conditions
in K10T-1 medium. P. fluorescens with expression vector without
insertion (PsD4-pEmpty) was used as negative control and P.
fluorescens complemented with vector expressing a P. fluorescens
diguanylate cyclase gcbB (PsD4-PsDGC) as a positive control.
gcbB expression was induced by presence of arabinose 0.2 % (p/v).
* P,0.001 vs PsD4. ** P,0.001 vs PsD4-pEmpty.
c-di-GMP regulates biofilm and motility in Bordetella
http://mic.sgmjournals.org 877
de Investigaciones Cientı́ficas de la Provincia de Buenos Aires (CICBA).
J. F. and F. S. are members of the Scientific Career of CONICET.
REFERENCES
Akerley, B. J. & Miller, J. F. (1993). Flagellin gene transcription in
Bordetella bronchiseptica is regulated by the BvgAS virulence control
system. J Bacteriol 175, 3468–3479.
Akerley, B. J., Monack, D. M., Falkow, S. & Miller, J. F. (1992). The
bvgAS locus negatively controls motility and synthesis of flagella in
Bordetella bronchiseptica. J Bacteriol 174, 980–990.
Amarasinghe, J. J., D’Hondt, R. E., Waters, C. M. & Mantis, N. J.
(2013). Exposure of Salmonella enterica Serovar Typhimurium to a
protective monoclonal IgA triggers exopolysaccharide production via
a diguanylate cyclase-dependent pathway. Infect Immun 81, 653–
664.
Amikam, D. & Galperin, M. Y. (2006). PilZ domain is part of the
bacterial c-di-GMP binding protein. Bioinformatics 22, 3–6.
Anantharaman, V. & Aravind, L. (2000). Cache – a signaling domain
common to animal Ca2+-channel subunits and a class of prokaryotic
chemotaxis receptors. Trends Biochem Sci 25, 535–537.
Conover, M. S., Mishra, M. & Deora, R. (2011). Extracellular DNA is
essential for maintaining Bordetella biofilm integrity on abiotic
surfaces and in the upper respiratory tract of mice. PLoS ONE 6,
e16861.
Cotter, P. A. & Miller, J. F. (1997). A mutation in the Bordetella
bronchiseptica bvgS gene results in reduced virulence and increased
resistance to starvation, and identifies a new class of Bvg-regulated
antigens. Mol Microbiol 24, 671–685.
Dombrecht, B., Vanderleyden, J. & Michiels, J. (2001). Stable RK2-
derived cloning vectors for the analysis of gene expression and gene
function in Gram-negative bacteria. Mol Plant Microbe Interact 14,
426–430.
Fernández, J., Sisti, F., Bottero, D., Gaillard, M. E. & Hozbor, D.
(2005). Constitutive expression of bvgR-repressed factors is not
detrimental to the Bordetella bronchiseptica–host interaction. Res
Microbiol 156, 843–850.
Galperin, M. Y. (2004). Bacterial signal transduction network in a
genomic perspective. Environ Microbiol 6, 552–567.
Galperin, M. Y. (2005). A census of membrane-bound and
intracellular signal transduction proteins in bacteria: bacterial IQ,
extroverts and introverts. BMC Microbiol 5, 35.
Galperin, M. Y. (2006). Structural classification of bacterial response
regulators: diversity of output domains and domain combinations.
J Bacteriol 188, 4169–4182.
Galperin, M. Y., Nikolskaya, A. N. & Koonin, E. V. (2001). Novel
domains of the prokaryotic two-component signal transduction
systems. FEMS Microbiol Lett 203, 11–21.
Goodnow, R. A. (1980). Biology of Bordetella bronchiseptica. Microbiol
Rev 44, 722–738.
Harvill, E. T., Cotter, P. A., Yuk, M. H. & Miller, J. F. (1999). Probing the
function of Bordetella bronchiseptica adenylate cyclase toxin by
manipulating host immunity. Infect Immun 67, 1493–1500.
Harvill, E. T., Preston, A., Cotter, P. A., Allen, A. G., Maskell, D. J. &
Miller, J. F. (2000). Multiple roles for Bordetella lipopolysaccharide
molecules during respiratory tract infection. Infect Immun 68, 6720–
6728.
Hengge, R. (2009). Principles of c-di-GMP signalling in bacteria. Nat
Rev Microbiol 7, 263–273.
Inatsuka, C. S., Xu, Q., Vujkovic-Cvijin, I., Wong, S., Stibitz, S., Miller,
J. F. & Cotter, P. A. (2010). Pertactin is required for Bordetella species
to resist neutrophil-mediated clearance. Infect Immun 78, 2901–
2909.
Irie, Y., Mattoo, S. & Yuk, M. H. (2004). The Bvg virulence control
system regulates biofilm formation in Bordetella bronchiseptica.
J Bacteriol 186, 5692–5698.
Jenal, U. & Malone, J. (2006). Mechanisms of cyclic-di-GMP signaling
in bacteria. Annu Rev Genet 40, 385–407.
Kolter, R. & Greenberg, E. P. (2006). Microbial sciences: the
superficial life of microbes. Nature 441, 300–302.
Kovach, M. E., Elzer, P. H., Hill, D. S., Robertson, G. T., Farris, M. A.,
Roop, R. M., II & Peterson, K. M. (1995). Four new derivatives of the
broad-host-range cloning vector pBBR1MCS, carrying different
antibiotic-resistance cassettes. Gene 166, 175–176.
Kulesekara, H., Lee, V., Brencic, A., Liberati, N., Urbach, J., Miyata, S.,
Lee, D. G., Neely, A. N., Hyodo, M. & other authors (2006). Analysis of
Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases
reveals a role for bis-(39–59)-cyclic-GMP in virulence. Proc Natl Acad
Sci U S A 103, 2839–2844.
Lai, T. H., Kumagai, Y., Hyodo, M., Hayakawa, Y. & Rikihisa, Y.
(2009). The Anaplasma phagocytophilum PleC histidine kinase and
PleD diguanylate cyclase two-component system and role of cyclic di-
GMP in host cell infection. J Bacteriol 191, 693–700.
Mattoo, S. & Cherry, J. D. (2005). Molecular pathogenesis,
epidemiology, and clinical manifestations of respiratory infections
due to Bordetella pertussis and other Bordetella subspecies. Clin
Microbiol Rev 18, 326–382.
McMillan, D. J., Shojaei, M., Chhatwal, G. S., Guzmán, C. A. & Walker,
M. J. (1996). Molecular analysis of the bvg-repressed urease of
Bordetella bronchiseptica. Microb Pathog 21, 379–394.
Merkel, T. J., Barros, C. & Stibitz, S. (1998). Characterization of the
bvgR locus of Bordetella pertussis. J Bacteriol 180, 1682–1690.
Mikkelsen, H., Ball, G., Giraud, C. & Filloux, A. (2009). Expression of
Pseudomonas aeruginosa CupD fimbrial genes is antagonistically
controlled by RcsB and the EAL-containing PvrR response regulators.
PLoS ONE 4, e6018.
Mishra, M., Parise, G., Jackson, K. D., Wozniak, D. J. & Deora, R.
(2005). The BvgAS signal transduction system regulates biofilm
development in Bordetella. J Bacteriol 187, 1474–1484.
Newell, P. D., Yoshioka, S., Hvorecny, K. L., Monds, R. D. & O’Toole,
G. A. (2011). Systematic analysis of diguanylate cyclases that promote
biofilm formation by Pseudomonas fluorescens Pf0-1. J Bacteriol 193,
4685–4698.
Pesavento, C., Becker, G., Sommerfeldt, N., Possling, A., Tschowri,
N., Mehlis, A. & Hengge, R. (2008). Inverse regulatory coordination of
motility and curli-mediated adhesion in Escherichia coli. Genes Dev
22, 2434–2446.
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